Center for Addiction Medicine

Extended Duration Varenicline for prevention of Relapse to Smoking in Patients with Schizophrenia

This investigator-initiated study provides study medication and additional funding to supplement NIDA R01 DA021245 ‘Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia’ to evaluate safety and efficacy of varenicline in smokers with schizophrenia.